HealthDay - WEDNESDAY, July 2 (HealthDay News) -- Drugs designed to controltype 2 diabetes should be subjected to more thorough safety reviews toensure they don't raise the risk of heart problems, U.S. Food and DrugAdministration advisers said Wednesday.
More...